The ability of a novel class of compounds, termed adamantylsubstituted retinoid-related molecules (ARRs) by several investigators to induce apoptosis in malignant cells has been well documented. 1, 2 While inducing death of malignant cells, several studies have documented that these compounds have no detrimental effects on normal cells. 3, 4 In addition, ST1926, an analog of the parent compound CD437, is now undergoing Phase I clinical trials. 3 We have previously shown the ability of the retinoid-related molecule 4-(3-Cl-(1-adamantyl)-4-hydroxyphenyl)-3-chlorocinnamic acid (3-Cl-AHPC) to induce apoptosis in a number of malignant cell types. 5 Furthermore, we and others have also reported that apoptosis induction by 3-Cl-AHPC requires NF-kB activation. 1, 6 NF-kB represents a complex family of proteins that have key roles in a variety of cellular processes, including oncogenesis, proliferation, inflammatory and stress responses as well as apoptosis. 7, 8 The NF-kB family consists of p50, p52, RelA(p65), c-Rel and RelB. 7, 8 Recent investigations have documented the presence of the following three major NF-kB-activating pathways. 7, 8 (1) A canonical pathway in which external stimuli through a number of intracellular cascades activate the IkB kinase (IKK) complex that in turn phosphorylates IkB and p105 followed by their polyubiquitination by the SCF bTrCP E3 ligase complex and their subsequent destruction. These events in turn result in the release of p50, p65 and c-Rel; their localization in the nucleus; formation of heterodimers and modulation of gene transcription. (2) A noncanonical pathway involving the processing of NF-kB2 p100 to generate p52-containing complexes preceded by NF-kB-inducing kinase (NIK) activation of a unique IKK signalosome consisting of IKKa homodimers. 7, 8 (3) DNA damage or oxygen stress induced NF-kB activation using an IKKindependent process. 9 Numerous studies using in vitro as well as in vivo model systems have documented a role for NF-kB in cell survival and the inhibition of cellular apoptosis. [10] [11] [12] Knockout of RelA resulted in an embryonic lethal phenotype in transgenic mice because of RelA's failure to inhibit tumor necrosis factor (TNF)-induced hepatocyte apoptosis. 10 Moreover, NF-kB was shown to block TNF-mediated apoptosis in a number of malignant and nonmalignant cell lines. 11 More recent studies have strongly suggested that NF-kB activation under specific situations may have an important role in the induction of apoptosis in certain cell types. Many of the studies examined the effects of inhibition of NF-kB activation on apoptosis induction and have shown that NF-kB inhibition blocked cellular apoptosis. 1 Other studies have shown that NF-kB activation by a number of therapeutic agents promoted cell death. 13 NF-kB activation by doxorubicin and daunorubicin in U2OS osteosarcoma cells promoted cell death. 13 Similar observations were made in colorectal carcinoma cell lines where activation of NF-kB was required for doxorubicin induction of apoptosis in these cells. 13 Although some observations have suggested that NF-kBmediated induction of apoptosis may be related to the activation of specific family members, other studies have suggested that this is not the case and that family members such as c-Rel and RelA can function as both pro-apoptotic or anti-apoptotic agents depending upon the context in which NF-kB is activated.
14 Here, we delineated the pathways by which 3-Cl-AHPC activates NF-kB. We also show that maximum 3-Cl-AHPC-mediated apoptosis and NF-kB activation require the combined activation of both IKKa in the noncanonical and IKKb in the canonical pathways.
3-Cl-AHPC mediates the enhanced expression of NIK, which then activates IKKa. Activated IKKa results in the phosphorylation and processing of NF-kB2p100 and the subsequent generation and nuclear translocation of p52.
Results
3-Cl-AHPC activates the canonical and noncanonical NF-jB pathways. We found that inhibition of 3-Cl-AHPCmediated NF-kB activation in human DU145 prostate and MDA-MB-468 breast cancer cells blocked 3-Cl-AHPC induction of apoptosis. 1 We examined the role of NF-kB activation in 3-Cl-AHPC apoptosis induction in KG-1 human leukemia cells using the NF-kB inhibitor JSH-23 that selectively blocks nuclear translocation of the NF-kB p65/ RelA subunit and its transcriptional activity. 15 Figure 1 3-Cl-AHPC-mediated phosphorylation of IKKa and IKKb, and activation of the NF-kB canonical and noncanonical pathways. (a) 3-Cl-AHPC activates NF-kB in KG-1 cells; cells were transduced with lentiviral NF-kB reporter (GFP) particles transiently for 48 h and then treated with 1 mM 3-Cl-AHPC for 24 h. (b) NF-kB activation inhibitor JSH-23 blocks 3-Cl-AHPC-mediated apoptosis. Induction of apoptosis and cell death was assessed using Annexin V-FITC labeling with propidium iodide (PI) staining; the percentage of apoptotic cells corresponds to the sum of percent noted in upper right (late apoptotic cells, annexin V and PI-positive cells) and lower right (early apoptotic cells, annexin V positive, PI-negative) quadrants. KG-1 cells were exposed to 1 mM 3-Cl-AHPC for 24 h. (c) 3-Cl-AHPC enhances phosphorylation of IKKa and IKKb. (d) 3-Cl-AHPC induces phosphorylation of NF-kBp65/RelA at Ser276. (e) 3-Cl-AHPC enhances phosphorylation of NF-kB2p100 followed by processing to p52 in both cell lines. (f) 3-Cl-AHPC induces increased RelB expression and the RelB binding with NF-kB2p100/p52. Cells were grown and exposed to vehicle or 3-Cl-AHPC (1.0 mM) for various times as described in Materials and Methods section. Columns represent mean of two independent experiments. Error bars indicate standard deviations. * and ** significantly different from control cells; and JSH-23 þ 3-Cl-AHPC from 3-Cl-AHPC treated cells, respectively (P-value is o0.05 and o0.01 as determined by t-test) 3-Cl-AHPC activation of NF-jB pathways in apoptosis L Farhana et al 3-Cl-AHPC resulted in a twofold NF-kB activation at 24 h in KG-1 cells (Figure 1a) . Inhibition of this activation by JSH-23 resulted in a 35% inhibition of 3-Cl-AHPC-mediated apoptosis (Figure 1b) . JSH-23 only blocks the NF-kB canonical pathway and not the noncanonical pathway that is still activated in the JSH-23-and 3-Cl-AHPC-treated cells; both pathways contribute to maximal apoptosis (see below), thus the noncanonical pathway still enhances apoptosis even in the presence of JSH-23. We have previously shown that 3-Cl-AHPC treatment of DU145 and MDA-MB-468 cells resulted in the IKKa kinase activation at 24 h as indicated by the increased phosphorylation of GST-IkBa. 1 3-Cl-AHPC activation of IKKb kinase was not noted at 24 h. Phosphorylation of the activation loops of IKKa and IKKb has been associated with their conformational change and IKK kinase activation. 7, 16 We examined 3-Cl-AHPC activation of IKKa and IKKb by assessing 3-Cl-AHPC-mediated phosphorylation of their activation loops at both early and late time points. 3-Cl-AHPC treatment of MDA-MB-468 cells resulted in rapid IKKb activation with maximum phosphorylation 7.5-fold noted at 6 h and its decrease to 3-fold at 24 h and total loss at 48 h ( Figure 1c and Supplementary Figure S1a 3-Cl-AHPC activation of the canonical pathway was documented by increased phosphorylation of the NF-kB p65/RelA at Ser276, whereas its activation of the noncanonical pathway was documented by phosphorylation of NF-kB2p100 and generation of p52 (Figures 1d and e) . Exposure of MDA-MB-468 to 3-Cl-AHPC was accompanied by increased phosphorylation of NF-kB2p100 with maximal phosphorylation noted at 24 and 6 h in MDA-MB-468 and KG-1 cells, respectively (Figure 1e ). In both cell lines, there were associated and correlated increases in the NF-kB2p100 levels and the p52 levels ( Figure 1e) . Activation of the noncanonical pathway has been shown to generate an increase in RelB/p52 heterodimer levels with the binding to unique consensus sequences. 17 3-Cl-AHPC-mediated activation of the noncanonical pathway also resulted in the markedly increased RelB levels and the binding of RelB to NF-kB2p100/p52 (Figure 1f Knockdown of IKKb had no effect on 3-Cl-AHPC-mediated NF-kB2p100 phosphorylation, whereas knockdown of IKKa delayed NF-kB2p100 phosphorylation to 48 h and decreased the levels of phosphorylated NF-kB2p100 ( Figure 3b ). Total inhibition of NF-kB2p100 phosphorylation would not be expected because activated IKKa was still present but at reduced levels.
The role of the NIK in the activation of the NF-kB noncanonical pathway has been well demonstrated. 17, 18 We therefore assessed the effect of 3-Cl-AHPC exposure on NIK levels. We found that incubation of MDA-MB-468 cells with 3-Cl-AHPC resulted in a sixfold increase in the NIK levels ( Figure 3c ). NIK expression in cells has been found to be tightly regulated by c-IAP1 and c-IAP2. 18 The E-3 ligases c-IAP1 and c-IAP2 have been found to inhibit NIK expression through its destruction by means of the proteasome pathway and thus inhibit activation of the NF-kB noncanonical pathway. 19 As expected, inhibition of the proteasome pathway resulted in a marked increase in NIK levels in the absence and presence of 3-Cl-AHPC (Figure 3d ).
Recent reports suggest that c-IAP1 and c-IAP2 degradation of NIK requires the formation of a regulatory complex containing c-IAP1, c-IAP2, TNF receptor-associated factors (TRAFs) TRAF2 and TRAF3 with subsequent binding of NIK. [20] [21] [22] TRAF2 and TRAF3 appear to have separate and unique roles. 20, 22 Exposure of MDA-MB-468 cells to 3-Cl-AHPC resulted in increased expression of TRAF2 and TRAF3 but only an increase in TRAF3 levels was noted in KG-1 cells after the addition of 3-Cl-AHPC (Figure 3e ), which was accompanied by decreased binding of NIK by TRAF2 (Figure 3e ). Interestingly, a significant decrease in binding of c-IAP1 by TRAF3 but not by TRAF2 in MDA-MB-468 cells occurred after 3-Cl-AHPC exposure (Figure 4a ). Increase in NIK levels in the cells after exposure to 3-Cl-AHPC was preceded by a decrease in c-IAP1 and XIAP levels within 6 h ( Figure 4b ). We therefore hypothesized that the 3-Cl-AHPCmediated decrease of c-IAP1 levels had a major role in the 3-Cl-AHPC activation of NF-jB pathways in apoptosis L Farhana et al associated increase in NIK levels. We assessed the effect of c-IAP1 overexpression on 3-Cl-AHPC-mediated activation of the noncanonical pathway and apoptosis induction in MDA-MB-468 cells. Elevated c-IAP1 levels inhibited 3-Cl-AHPCmediated apoptosis as well as 3-Cl-AHPC-mediated increase in NIK levels (Figures 4c-e; Supplementary Figure S2a) . We examined the potential mechanisms by which 3-Cl-AHPC inhibited c-IAP1 levels using inhibitors to the proteasome (MG-132), lysosomal (CA074Me) and caspase (ZVAD-fmk) pathways. Inhibition of the proteasome pathway did not block 3-Cl-AHPC-mediated decrease of c-IAP1 levels (Supplementary Figure S2b ) and apoptosis (Supplementary Figure S2c) in MDA-MB-468 cells. In addition, there was no evidence of c-IAP1 ubiquitination after 3-Cl-AHPC exposure (data not shown). Use of an inhibitor of the lysosomal pathway, CA074Me, also had no effect on 3-Cl-AHPC-mediated decrease in c-IAP1 levels (Supplementary Figure S2d) . Treatment of the cells with the proteasome or lysosomal inhibitors resulted in the degradation of c-IAP1, whereas the addition of the caspase pathway inhibitor ZVAD-fmk completely blocked 3-Cl-AHPC-mediated decrease of c-IAP1 levels (Supplementary Figure S2d ).
Role of Cdc37 in 3-Cl-AHPC-mediated IKK phosphorylation. We have previously shown that 3-Cl-AHPC-mediated IKK activation is associated with the enhanced binding 1 The association of chaperones Cdc37 and HSP90 with the IKK complex is required for ligandmediated IKK activation, including TNFa-mediated IKK activation. 8, 23 It has been shown that Cdc37 recruits HSP90 to the IKK complex through the direct interaction between Cdc37 and the catalytic region of IKKa/b. 23 Exposure of MDA-MB-468 cells to 3-Cl-AHPC resulted in the increased binding of Cdc37 to IKKa at 6 h ( Figure 5a ); this was accompanied by an enhanced association between Cdc37 to HSP90 (Figure 5a ). We therefore examined whether Cdc37 has a role in 3-Cl-AHPC-mediated IKKa/b activation and induction of apoptosis using shRNA to decrease Cdc37 expression in MDA-MB-468 cells (Supplementary Figure S2e) . Knockdown of Cdc37 inhibited 3-Cl-AHPC-mediated phosphorylation of both IKKa and IKKb (Figure 5b ) and inhibited both 3-Cl-AHPC-and TNFamediated NF-kB activation in cells (Figure 5c ) as well as 3-Cl-AHPC-mediated apoptosis in MDA-MB-468 cells (Figure 5d ). In addition, knockdown of Cdc37 levels in MDA-MB-468 cells markedly inhibited 3-Cl-AHPC-mediated enhanced HSP90 binding to IKKa (Figure 5e) . Thus, the recruitment by Cdc37 of HSP90 to the IKKs is essential for 3-Cl-AHPC-mediated NFkB activation and the induction of apoptosis. (Figure 6b ). In addition, TNFa exposure did not result in significant apoptosis induction in either MDA-MB-468 or KG-1 cells (Figures 6c and d) . Thus, despite TNFa-mediated increase in IKKb phosphorylation and activation and the presence of constitutively phosphorylated/activated IKKa in KG-1, neither was there induction of apoptosis (Figures 6a and c) nor was there a decrease in c-IAP1, XIAP or phosphoBad levels in these cells (Figure 6b ). These results imply that in addition to 3-Cl-AHPC-enhanced IKKa and IKKb phosphorylation/activation, additional 3-Cl-AHPC-mediated events must occur for the induction of apoptosis.
Discussion NF-kB is well known to function in an anti-apoptotic manner, but we have previously reported that 3-Cl-AHPC-mediated apoptosis requires NF-kB activation. 1 Here, we showed that IKKa and IKKb phosphorylation/activation were independent of each other; knockdown of IKKb had no effect on 3-Cl-AHPC-mediated IKKa phosphorylation/activation. We have previously shown that HSP90 is required for 3-Cl-AHPC activation of IKKa and IKKb. 1 We have now shown that Cdc37 is also essential for 3-Cl-AHPC-mediated IKKa and IKKb activation; inhibition of Cdc37 expression resulted in decreased association of IKKa with HSP90 as well as inhibition of 3-Cl-AHPC-mediated apoptosis.
3-Cl-AHPC enhanced NIK expression resulted in the increased binding of NIK to TRAF3. We speculate that the complex of NIK and TRAF3 resulted in the activation of IKKa through NIK phosphorylation of IKKa. A number of investigators have documented that IKKb-mediated NF-kB activation occurs through the canonical pathway, whereas IKKa-mediated NF-kB activation occurs primarily through the noncanonical pathway. 18, 24, 25 NIK is usually expressed at extremely low levels in cells. 25 TRAF3 that possesses ubiquitin E3 ligase activity targets NIK degradation through the proteasome pathway, and the induction of the noncanonical pathway involves TRAF3 degradation with the associated enhancement of NIK expression. [24] [25] [26] We have found that MDA-MB-468 exposure to 3-Cl-AHPC resulted in increased NIK expression, which was accompanied by increases in TRAF2 and TRAF3 levels. NIK was found to phosphorylate the T-loop serine of IKKa resulting in IKKa activation with the subsequent IKKa-mediated phosphorylation of NF-kB2p100 at the C-terminal serines to trigger ubiquitination and proteasomal processing of NF-kB2p100. 18 ,24 3-Cl-AHPC-enhanced NIK expression resulted in IKKa activation with concomitant NF-kB2p100 phosphorylation, which was accompanied by increased p52 levels. Interestingly, we found an increase in NF-kB2p100 levels rather than a decrease during 3-Cl-AHPC-enhanced phosphorylation/degradation of NF-kB2p100. A similar
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** 26 who found there was a progressive increase in NF-kB2p100 and p52 levels after treatment of EVSA-T human breast carcinoma cells with an IAP antagonist. Lombardi et al. 27 found that the NF-kBp65 subunit enhances the activation of the NF-kB2 promoter. We have previously reported that 3-Cl-AHPC enhances IkBa degradation through the proteasome pathway with the release of the NF-kBp65 subunit and its translocation to the nucleus. Thus, we speculate that 3-Cl-AHPC activation of p65 may result in enhanced NF-kB2p100 expression.
TRAF3 has been found to be associated with NIK, which allows it to recruit TRAF2 along with associated c-IAP1 or c-IAP2. The recruited c-IAP1 or c-IAP2 can then catalyze NIK ubiquitination and degradation. 20, 21, 26 Thus, the 3-Cl-AHPCmediated decrease in c-IAP1 levels may result in enhanced NIK levels and IKKa activation. c-IAP1 and c-IAP2 as well as XIAP appear to have essential roles in genotoxic stressinduced NF-kB activation. 28 XIAP regulates the activation of the upstream kinase TAK1 and couples activated TAK1 to the IKK complex. XIAP expression is essential for camptothecinand etoposide-mediated NF-kB activation. c-IAP1 mediated NEMO ubiquitination in the same pathway, whereas c-IAP2 regulated a downstream event and was also essential for camptothecin-and etoposide-mediated as well as doxorubicin-mediated NF-kB activation. 28 Valli et al. 3 have shown that ST1926 and CD437, analogs of 3-Cl-AHPC, induce DNA double-strand breaks in the acute myelogenous cell line NB4; these investigators speculated that this may be the mechanism by which ST1926 and CD437 induce cell death. The fact that 3-Cl-AHPC inhibits the expression of c-IAP1 as well as Cells were grown and exposed to vehicle or 3-Cl-AHPC (1 mM) for various time; immunoprecipitations and immunoblots were performed as described in Material and Methods section. Columns represent mean of two independent experiments, and error bars indicate standard deviations. * and ** significantly different from 3-Cl-AHPC-treated sh-vector cells (P-value is o0.05 and o0.01, respectively, as determined by t-test)
3-Cl-AHPC activation of NF-jB pathways in apoptosis L Farhana et al of XIAP and yet requires NF-kB activation for apoptosis induction suggests that genotoxic stress-induced NF-kB activation is not involved in 3-Cl-AHPC-mediated apoptosis. The 3-Cl-AHPC-mediated decrease in c-IAP1 levels was blocked by the addition of the caspase inhibitor ZVAD-fmk. This is somewhat perplexing because we did not find evidence of activation of the caspase pathway at 6 h when the decrease in c-IAP1 levels was noted in KG-1 cells. A number of investigators have shown that although IKKa and IKKb activation are both involved in NF-kB activation, the IKKb and NEMO complex transmits distinct signals and regulates the expression of different genes than noted with IKKa. 29, 30 This is further supported by the observation that IKKa and IKKb knockout mice display markedly different phenotypes. 31 In addition to NF-kB activation, IKKa regulates a number of NF-kB-independent developmental processes. It has been shown that nuclear IKKa may have a role in the transcriptional activation of a number of genes at the histone level through its ability to phosphorylate and modify histone structure. 31 A number of diverse mechanisms have been proposed through which adamantyl-substituted retinoids induce apoptosis in malignant cells; [32] [33] [34] whether these are cell-type specific remains to be determined. These pathways have included activation of the c-JunNH 2 -terminal kinase, DNA adduct formation and TR3 translocation to mitochondria, and its binding to Bcl-2. Interestingly, several investigators have found that adamantyl arotinoids possessing an internal chalcone group inhibit the IKKb kinase. 34, 35 Whether the presence of the chalcone group is entirely responsible for this difference in biological activity remains to be determined. We found that 3-Cl-AHPC as well as the parent compound AHPN and its analogs bind to the orphan receptor SHP. 36 Although SHP has been shown to heterodimerize to a number of nuclear receptors resulting in the inhibition of their ability to induce the transcriptional activity of a number of genes, SHP has been found to bind to the NF-kBp65 subunit and activate the NF-kB nuclear receptor. 37 Inhibition of SHP expression blocks ARR-mediated NF-kB induction and apoptosis. 38 Thus, SHP and NF-kB both appear to be interlinked and essential for ARR-apoptosis induction.
On the basis of our results, we proposed a model to illustrate 3-Cl-AHPC-mediated NF-kB activation in canonical and noncanonical pathways (Figure 7 ). In this model, we have found that exposure of cells to 3-Cl-AHPC resulted in enhanced binding of Cdc37/HSP90 to IKKa and the activation of both the NF-kB canonical and noncanonical pathways ( Figure 7) . Activation of the NF-kB canonical pathway resulted in the proteasomal degradation of IkBa, translocation of p50 and p65 to the nucleus and NF-kB activation ( Figure 7 ). delineated. The involvement of signaling complexes including TRAF2, TANK and TBK1 are also under study. 39 Our results reveal that NF-kB activation contributes a role in ARR-mediated apoptotic pathway and activation of both NF-kB pathways was required for maximal 3-Cl-AHPC-mediated apoptosis.
Materials and Methods
Reagents. 3-Cl-AHPC was synthesized as described. 5 DMEM-F12 and RPMI 1640 medium, and fetal bovine serum (FBS) were purchased from Invitrogen (Carlsbad, CA, USA). Antibodies and their sources were as follows: antibodies for phospho-IKKa/b (2681), and phospho-NF-kB2p100-p52 (4810), non-phospho-NF-kB2p100-p52 (3017), phospho-NF-kBp65 (3037), phospho-Bad (9291); IKKg 
, IKKb
À/À and IKKg À/À -knockout stable cell lines was determined by flow cytometry using Annexin V-FITC labeling with propidium iodide staining (Annexin V-FITC apoptosis Detection Kit 1; BD Biosciences, San Diego, CA, USA). The fluorochrome-coupled Annexin V binds to phosphatidylserine in apoptotic cells, which is exposed on the outer leaflet of the plasma membrane; 40 the results were analyzed following the guidelines of Galluzzi et al. 40 Data acquisition was carried out on a FACS Calibur flow cytometer (BD Biosciences) and analyzed with CellQuest software (BD Biosciences).
Western blots and immunoprecipitation. Cells were extracted with lysis buffer containing 25 mM Tris-Cl buffer (pH 8.0), 150 mM NaCl, 0.2% nonidet P-40, 10% glycerol, 10 mM NaF, 8 mM b-glycerophosphate, 0.2 mM Na 3 VO 4 , 1 mM DTT and 10 ml/ml protease inhibitor cocktail (Sigma-Aldrich, St Louis, MO, USA) for the detection of phospho-protein. Immunoprecipitations and western blots were performed as we previously described. 1 Transfection. Transfection of MDA-MB-468 cells for NF-kB activation was performed using the calcium phosphate method.
1 Cells were treated with 3-Cl-AHPC after 36 h of post-transfection of NF-kB reporter plasmid and incubated for 24 h before luciferase and b-galactosidase assays were performed. Cignal lentiviral NF-kB reporter (GFP) particles were used to transduce KG-1 cells either transiently using the manufacturer's instructions (SABiosciences, Frederick, MD, USA), and luciferase assay and GFP fluorescence reporter protein assays were performed using the BioTek Synergy HT (BioTek, Winooski, VT, USA). 
